RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
          
          https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
        Thromb Haemost 2001; 86(04): 1126-1127
DOI: 10.1055/s-0037-1616550
   DOI: 10.1055/s-0037-1616550
Letters to the Editor
   Effective Prophylaxis with Daily Recombinant Factor VIIa (rFVIIa-Novoseven) in a Child with High Titre Inhibitors and a Target Joint
Autoren
Weitere Informationen
            
               
                  
            
         
      
   Publikationsverlauf
Received
                     21. Mai 2001
Accepted
                     21. Mai 2001
Publikationsdatum:
09. Dezember 2017 (online)
- 
            
References
 - 1 Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, Birch K, Glazer S, Roberts HR. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994; 55 (Suppl. 06) 638-48.
 - 2 Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80 (Suppl. 05) 773-8.
 - 3 Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998; 80 (Suppl. 06) 912-8.
 - 4 Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105 (Suppl. 04) 1109-13.
 - 5 Aronstam A, Arblaster PG, Rainsford SG, Turk P, Slattery M, Alderson MR, Hall DE, Kirk PJ. Prophylaxis in haemophilia: a double-blind controlled trial. Br J Haematol 1976; 33 (Suppl. 01) 81-90.